2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow Matrix-M: new trials by email Literature Review of Matrix-M trials Research Report on Matrix-M
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Immunogenicity and ex Vivo Efficacy of Pfs25-IMX313/Matrix-M in Healthy Volunteers in Bagamoyo, Tanzania. Pfs25-IMX313 (10ug)/Matrix-M (50ug), Pfs25-IMX313 (50ug)/Matrix-M (50ug), Pfs25-IMX313 (50ug)/Matrix-M (50ug) & Pfs25-IMX313 (10ug)/Matrix-M (50ug) - Malaria,Falciparum | Phase 1 | Terminated | University of Oxford | 34 | 2021-05-25 | 2025-01-27 |
| VAC077: Safety and Immunogenicity of the Pfs25-IMX313/Matrix-M Vaccine Pfs25-IMX313/Matrix-M1 - Malaria,Falciparum | Phase 1 | Terminated | University of Oxford | 1 | 2019-09-27 | 2020-09-29 |
Tanzania (1) · United Kingdom (1)
Angela Minassian (1) · Angela Minassian, PhD (1)